Sipeimine
CAS No. 61825-98-7
Sipeimine( Kashmirine | Sipeimine )
Catalog No. M18907 CAS No. 61825-98-7
Sipeimine has antiasthmatic effect, on tracheal M receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 110 | In Stock |
|
| 5MG | 116 | In Stock |
|
| 10MG | 211 | In Stock |
|
| 25MG | 353 | In Stock |
|
| 50MG | 508 | In Stock |
|
| 100MG | 724 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSipeimine
-
NoteResearch use only, not for human use.
-
Brief DescriptionSipeimine has antiasthmatic effect, on tracheal M receptor antagonist.
-
DescriptionImperialine is a compound in the traditional Chinese medicine chuanbeimu (Bulbus Fritillariae Cirrhosae) that has been used as antitussive/expectorant.
-
In Vitro——
-
In Vivo——
-
SynonymsKashmirine | Sipeimine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number61825-98-7
-
Formula Weight429.64
-
Molecular FormulaC27H43NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 8.33 mg/mL (19.39 mM)
-
SMILESCC1CCC2C(C3CCC4C(C3CN2C1)CC5C4CC(=O)C6C5(CCC(C6)O)C)(C)O
-
Chemical NameCevan-6-one, 3,20-dihydroxy-, (3-beta,5-alpha,17-beta)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
L-(-)-Mannose
L-(-)-Mannose ((2R,3R,4S,5S)-2,3,4,5,6-pentahydroxyhexanal) is a naturally occurring non-reducing sugar commonly used as a food additive.
-
Methysticin b
Methysticin, a major kavalactone extracted from kava, can induce CYP1A1.
-
(R)-Omeprazole Sodiu...
(R)-Omeprazole (sodium) (Standard) is the analytical standard of (R)-Omeprazole (sodium). This product is intended for research and analytical applications. (R)-Omeprazole sodium is a gastric acid resistant compound with activity to inhibit gastric acid secretion. (R)-Omeprazole sodium is metabolized in vivo, and its metabolism is primarily affected by cytochrome P450 enzymes. The interaction between (R)-Omeprazole sodium and mannitol may affect its bioavailability in formulations. (R)-Omeprazole sodium exhibits reversible direct and metabolism-dependent inhibition of CYP2C19.
Cart
sales@molnova.com